Search your stocks

Share

Profile

MOREPENLABMorepen Laboratories Ltd.

54(+0.02%)

1W: +5.41%

1M: -4.53%

1Y: +18.79%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth of 5.72% in the latest quarter shows stable demand.
Net profit margin improved to 7.93%, indicating better cost management.
Operating profit margin increased to 9.37%, reflecting operational efficiency.

NEGATIVES

Net profit decreased by 41.3% compared to the same quarter last year.
Expenses surged by 10.7%, affecting overall profitability.
Operating profit declined by 7.3% from the previous quarter, indicating pressure on margins.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		421.77	444.55	423.07	455.22	437.73	452.78	465.85	425.24
Expenses		396.32	404.60	385.12	410.48	396.69	422.91	444.75	414.13
Operating Profit		25.44	39.95	37.96	44.74	41.03	29.87	21.10	11.11
Other Income		3.24	4.07	4.24	3.43	4.99	5.34	4.61	4.41
Interest		0.46	2.17	0.80	1.15	1.18	1.34	4.67	4.04
Depreciation		7.69	8.45	9.62	5.73	1.86	4.93	16.47	9.03
Profit Before Tax		28.68	44.02	41.74	48.17	46.02	35.21	25.72	15.52
Tax		7.43	12.03	13.46	12	11.17	8.52	5.40	4.11
Net Profit		21.26	31.99	28.28	36.17	34.85	26.69	20.32	11.41
Eps in Rs		0.42	0.63	0.54	0.71	0.65	0.49	0.35	0.20